Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
19
INBS Quote, Financials, Valuation and Earnings
Last price:
$4.48
Seasonality move
:
-50.57%
Day range:
$4.03 - $4.50
52-week range:
$3.70 - $25.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.38x
P/B ratio:
0.35x
Volume:
42.3K
Avg. volume:
151K
1-year change:
-80.24%
Market cap:
$3.9M
Revenue:
$3.1M
EPS (TTM):
-$10.97
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Intelligent Bio Solutions, Inc. has 2826.83% upside to fair value with a price target of -- per share.
INBS vs. S&P 500
-
Over the past 5 trading days, Intelligent Bio Solutions, Inc. has overperformed the S&P 500 by 0.37% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Intelligent Bio Solutions, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Intelligent Bio Solutions, Inc. has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Intelligent Bio Solutions, Inc. reported revenues of $896.8K.
Earnings Growth
-
Intelligent Bio Solutions, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Intelligent Bio Solutions, Inc. reported earnings per share of -$2.82.
Enterprise value:
4.9M
EV / Invested capital:
0.38x
Price / LTM sales:
2.38x
EV / EBIT:
--
EV / Revenue:
1.37x
PEG ratio (5yr expected):
-0.01x
EV / Free cash flow:
-0.50x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$467.4K
Return On Assets:
-104.52%
Net Income Margin (TTM):
-316.5%
Return On Equity:
-215.68%
Return On Invested Capital:
-179.5%
Operating Margin:
-298.99%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | $2.5M | $3M | $3.6M | $607.5K | $896.8K | |
| Gross Profit | -$652.2K | -$176.1K | $467.4K | -$82.1K | $177.8K | |
| Operating Income | -$10M | -$11.3M | -$11.6M | -$2.4M | -$2.7M | |
| EBITDA | -$8.9M | -$10M | -$10.4M | -$2.1M | -$2.4M | |
| Diluted EPS | -$8.08 | -$7.90 | -$10.97 | -$4.96 | -$2.82 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $14.1M | $6.4M | $2.9M | $3.9M | $12.2M | |
| Total Assets | $15.2M | $18M | $8.8M | $8.7M | $17.7M | |
| Current Liabilities | $4M | $4.8M | $5.2M | $4.4M | $5.1M | |
| Total Liabilities | $4M | $6.2M | $5.7M | $4.5M | $6.8M | |
| Total Equity | $10M | $10.3M | $3.2M | $4.2M | $10.9M | |
| Total Debt | -- | $1.9M | $830.2K | $420K | $1.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$7.3M | -$10.1M | -$9.4M | -$2.3M | -$1.6M | |
| Cash From Investing | -$71.3K | -$173.1K | -$321.3K | -$8.9K | -$28.5K | |
| Cash From Financing | $5.5M | $11.4M | $8.2M | $630.7K | $694.8K | |
| Free Cash Flow | -$7.4M | -$10.2M | -$9.7M | -$2.3M | -$1.7M | |
INBS
Sector
Market Cap
$3.9M
$25.3M
Price % of 52-Week High
16.4%
49.41%
Dividend Yield
0%
0%
Shareholder Yield
-91.75%
-1.6%
1-Year Price Total Return
-80.24%
-17.71%
Beta (5-Year)
4.581
0.490
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$4.24
200-day SMA
Sell
Level
$11.98
Bollinger Bands (100)
Sell
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$5.08
Relative Strength Index (RSI14)
Sell
Level
35.76
ADX Line
Neutral
Level
0
Williams %R
Neutral
Level
-78.6096
50-day SMA
Sell
Level
$7.98
MACD (12, 26)
Sell
Level
-1.21
25-day Aroon Oscillator
Sell
Level
-72
On Balance Volume
Neutral
Level
--
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-13.5109)
Sell
CA Score
(Annual)
Level (-4.8915)
Sell
Beneish M-Score
(Annual)
Level (-0.2061)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (9.3044)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.
Stock Forecast FAQ
In the current month, INBS has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The INBS average analyst price target in the past 3 months is --.
-
Where Will Intelligent Bio Solutions, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Intelligent Bio Solutions, Inc. share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Intelligent Bio Solutions, Inc.?
Analysts are divided on their view about Intelligent Bio Solutions, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Intelligent Bio Solutions, Inc. is a Sell and believe this share price will drop from its current level to --.
-
What Is Intelligent Bio Solutions, Inc.'s Price Target?
The price target for Intelligent Bio Solutions, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is INBS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Intelligent Bio Solutions, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of INBS?
You can purchase shares of Intelligent Bio Solutions, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Intelligent Bio Solutions, Inc. shares.
-
What Is The Intelligent Bio Solutions, Inc. Share Price Today?
Intelligent Bio Solutions, Inc. was last trading at $4.48 per share. This represents the most recent stock quote for Intelligent Bio Solutions, Inc.. Yesterday, Intelligent Bio Solutions, Inc. closed at $4.10 per share.
-
How To Buy Intelligent Bio Solutions, Inc. Stock Online?
In order to purchase Intelligent Bio Solutions, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get INBS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
INBS
Sector
P/E ratio
--
22.85x
PEG ratio
-0.01x
-0.01x
P/B ratio
0.35x
1.78x
Price / LTM sales
2.38x
1.52x
Growth Metrics
INBS
Sector
Revenue growth
47.62%
3.33%
Earnings growth
43.22%
11.64%
Revenue (5-year growth)
--
6.41%
Earnings forecast
--
-$0.20
Profitability
INBS
Sector
Profitability FY 2025
$39K
$2.3M
Return on invested capital
-179.5%
-33.31%
Return on assets
-104.52%
-29.79%
Return on equity
-215.68%
-38.98%
Earnings Date
Last Earnings Date
Mar
5
Next Earnings Date
Mar
5
Estimated Next Earnings Date
Jun
4
Balance Sheet
INBS
Sector
Total cash
$740.4K
$24.1M
Short term investments
--
$23.8M
Total assets
$8.3M
$70.1M
Long term debt
$1.5M
$2.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
47
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
34
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Sell
46
ZD alert for Mar 4
Ziff Davis, Inc. [ZD] is up 3.64% over the past day.
Buy
54
KORU alert for Mar 4
Direxion Daily MSCI South Korea Bull 3X Shares [KORU] is up 5.43% over the past day.
Sell
40
PSIX alert for Mar 4
Power Solutions International, Inc. [PSIX] is down 1.4% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
